BDBM148434 US8962637, 165

SMILES: Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(cc3)S(=O)(=O)NC3CC3)ncc2C1

InChI Key: InChIKey=SCDTVQOOFJOJPO-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 148434   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM148434 (US8962637, 165) Show SMILES Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(cc3)S(=O)(=O)NC3CC3)ncc2C1 Show InChI InChI=1S/C31H29F3N6O3S/c1-19-5-6-25(36-29(41)20-3-2-4-22(15-20)31(32,33)34)16-28(19)40-14-13-27-21(18-40)17-35-30(38-27)37-23-9-11-26(12-10-23)44(42,43)39-24-7-8-24/h2-6,9-12,15-17,24,39H,7-8,13-14,18H2,1H3,(H,36,41)(H,35,37,38)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Debiopharm S.A.; Aurigene Discovery Technologies Ltd. US Patent					Assay Description Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for J...				US Patent US8962637 (2015) BindingDB Entry DOI: 10.7270/Q2MS3RGN
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM148434 (US8962637, 165) Show SMILES Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1N1CCc2nc(Nc3ccc(cc3)S(=O)(=O)NC3CC3)ncc2C1 Show InChI InChI=1S/C31H29F3N6O3S/c1-19-5-6-25(36-29(41)20-3-2-4-22(15-20)31(32,33)34)16-28(19)40-14-13-27-21(18-40)17-35-30(38-27)37-23-9-11-26(12-10-23)44(42,43)39-24-7-8-24/h2-6,9-12,15-17,24,39H,7-8,13-14,18H2,1H3,(H,36,41)(H,35,37,38)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	54	n/a	n/a	n/a	n/a	n/a	n/a
Debiopharm S.A.; Aurigene Discovery Technologies Ltd. US Patent					Assay Description Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for J...				US Patent US8962637 (2015) BindingDB Entry DOI: 10.7270/Q2MS3RGN
					More data for this Ligand-Target Pair